Scientists discover a new way to prevent secondary breast cancer
Scientists have discovered why breast cancer cells that have spread to the lungs may "wake up" following years of sleep, forming incurable secondary tumors.
Mar 13, 2023
0
150
Heterocyclic Compounds: News and Research on Imatinib Mesylate
MeSH tree: D03.383.606.405
Countering pharma's expensive gaming of the drug patent system
Biomedical innovation reached a new era during the COVID-19 pandemic as drug development went into overdrive. But the ways that brand companies license their patented drugs grant them market monopoly, preventing other entities ...
Dec 6, 2022
0
38
Are drug companies the villain? New study questions claims of 'evergreening'
For years, brand drug companies have been villainized for "evergreening" or manipulating the law to extend the period of exclusivity for drugs beyond their 20-year patent—a practice critics say unfairly prevents competition ...
Nov 3, 2022
0
4
First-ever licencing deal struck for cancer drug
Pharmaceutical giant Novartis has signed a licensing agreement increasing access to a vital leukaemia treatment, a UN-backed public health organisation said Thursday, marking the first-ever such agreement for a cancer drug.
Oct 20, 2022
0
2
High magnetic field reduces side effects caused by anti-cancer drug imatinib
Researchers led by Prof. Zhang Xin at the Hefei Institutes of Physical Science of the Chinese Academy of Sciences (CAS) combined the 9.4 T static magnetic field (SMF) with a commonly used anti-cancer drug imatinib mesylate ...
Oct 14, 2022
0
7
Swiss drugmaker Novartis to spin off generics unit Sandoz
Swiss pharmaceuticals company Novartis said Thursday that it plans to spin off its generics subsidiary Sandoz, which generated nearly $10 billion in revenue last year.
Aug 25, 2022
0
17
Chemotherapy drugs from 'rogue' online pharmacies could endanger leukemia patients
Patients seeking to purchase chemotherapy drugs online face a confusing array of websites, over half of which potentially operate unsafely or illegally, finds a new study in the July 2022 issue of JNCCN—Journal of the National ...
Jul 28, 2022
0
14
